"Item Id","Item URI","Dublin Core:Title","Dublin Core:Subject","Dublin Core:Description","Dublin Core:Creator","Dublin Core:Source","Dublin Core:Publisher","Dublin Core:Date","Dublin Core:Contributor","Dublin Core:Rights","Dublin Core:Relation","Dublin Core:Format","Dublin Core:Language","Dublin Core:Type","Dublin Core:Identifier","Dublin Core:Coverage","Item Type Metadata:Bibliography","Item Type Metadata:Biographical Text","Item Type Metadata:Occupation","Item Type Metadata:Death Date","Item Type Metadata:Birthplace","Item Type Metadata:Text","Item Type Metadata:Player","Item Type Metadata:Access","Item Type Metadata:Alternate URL","Item Type Metadata:Citation","Item Type Metadata:Accessibility","Item Type Metadata:Abstract","Item Type Metadata:Read Online","Item Type Metadata:Additional Exercise","Item Type Metadata:Email Body","Item Type Metadata:Interviewer","Item Type Metadata:Interviewee","Item Type Metadata:Location","Item Type Metadata:Transcription","Item Type Metadata:Local URL","Item Type Metadata:Original Format","Item Type Metadata:Physical Dimensions","Item Type Metadata:Duration","Item Type Metadata:Compression","Item Type Metadata:Producer","Item Type Metadata:Director","Item Type Metadata:Bit Rate/Frequency","Item Type Metadata:Time Summary","Item Type Metadata:Birth Date","Item Type Metadata:Subject Line","Item Type Metadata:From","Item Type Metadata:To","Item Type Metadata:CC","Item Type Metadata:BCC","Item Type Metadata:Number of Attachments","Item Type Metadata:Standards","Item Type Metadata:Objectives","Item Type Metadata:Materials","Item Type Metadata:Lesson Plan Text","Item Type Metadata:URL","Item Type Metadata:Event Type","Item Type Metadata:Participants","PDF Text:Text",tags,file,itemType,collection,public,featured
1564,https://repository.netecweb.org/items/show/1564,"Vaccines and maternal health Q&A: Dr. Denise Jamieson","Treatment & Care","Are vaccines safe for women who are pregnant? Hope to be pregnant? Join Emory infectious diseases and OB-GYN expert Dr. Denise Jamieson for a live discussion with Emory public health expert Dr. Jodie Guest",Emory,,,2021-05-12,"2022-09-27 - general asset review - Treatment & Care group
2022-07 by Kari, Special Populations Treatment & Care group (both 1 yr)
2023-12-15 by Clayton Mowrer, Special Populations Treatment & Care group",,,,,,,2024-09-27,,,,,,,"
",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.facebook.com/EmoryUniversity/videos/283185166802377,,,,"2019-nCoV,Coronavirus,COVID-19,Labor and Delivery,Neonates,Not updated,Pregnancy,R-SP,R-T&C,Vaccine Study",https://repository.netecweb.org/files/original/64c50f01f5416aac379037dbc4ea7d66.png,Video,Develop,1,0
1343,https://repository.netecweb.org/items/show/1343,"Change in the Incidence of Stillbirth and Preterm Delivery During the COVID-19 Pandemic","Treatment & Care","High rates of preterm birth and cesarean delivery have been reported in women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, studies have inadequate power to assess uncommon outcomes like stillbirth (fetal death ≥24 weeks’ gestation).
The authors published a follow up to this article:
","Khalil, A., P. von Dadelszen, T. Draycott, A. Ugwumadu, P. O'Brien, and L. Magee. ",,,2020-07-10,"2022-09-27 - general asset review - Treatment & Care group
2023-12-15 by Clayton Mowrer, Special Populations Treatment & Care group - 3 years - note ""New asset to replace""",,,,,Publication,,2026-09-27,,,,,,,,,,"Khalil, A., P. von Dadelszen, T. Draycott, A. Ugwumadu, P. O'Brien, and L. Magee. 2020. ""Change in the Incidence of Stillbirth and Preterm Delivery During the COVID-19 Pandemic."" Jama 324 (7):705-6.
","Free online on JAMA and Lancet.",,https://jamanetwork.com/journals/jama/fullarticle/2768389,,,,,,,,,,,,,,,,,,,,,,,,,,,https://pubmed.ncbi.nlm.nih.gov/32648892/,,,,"2019-nCoV,Clinical Care,Coronavirus,COVID-19,Labor and Delivery,Neonates,Not updated,Pregnancy,R-Res&Pub,R-SP,R-T&C,SARS-CoV-2",,Publication,Discover,1,0
1299,https://repository.netecweb.org/items/show/1299,"Cuidados durante COVID-19 sobre pacientes de partos laborales","Elementos en Español","COVID-19 Considerations for Labor & Delivery Patients in Spanish.",NETEC,,,2020-07-02,,,,,,,,2024-01-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Coronavirus,COVID-19,Español,Labor and Delivery,Laboratory Testing,Postpartum,Pregnancy,R-SP,Spanish",https://repository.netecweb.org/files/original/8f5bcc6f0785195057e85011ce7daa0e.pdf,Guide,,1,0
1205,https://repository.netecweb.org/items/show/1205,"Caring for COVID-19 Labor and Delivery Patients","Treatment & Care","Get continuing education credit, and cover the approach to care for COVID patients and those under investigation for labor and delivery.
See the related webinar on COVID-19 and Labor and Delivery patients.
See the related flyer on COVID-19 and Labor and Delivery patients.",NETEC,,,2020-06-16,"2022-09-27 - general asset review - Treatment & Care group
2022-07 by Kari, Special Populations Treatment & Care group - tagged Archive - no more reviews
2023-03-03 - un-mark archive - in SPORSA",,"Y - D0.1Tx/D0.2Tx Qualtrics # 826",,,"Online Course",,2024-03-03,,,,,,,,"Free online with free account",,,,,,,,,,,,,,,"Self-paced
1 credit ",,,,,,,,,,,,,,"TARGET AUDIENCE
This enduring material is intended primarily for healthcare workers and teams which may include but are not limited to, medical and nursing staff, administration, education/training leadership, and infection control leadership. Staff specializing in emergency management, communications, specialized clinical areas, laboratory, facilities management and environmental services are also welcome.
EDUCATIONAL OBJECTIVES
At the conclusion of this enduring material, the participant should be better able to:
- Identify techniques to plan for appropriate PPE response
- Discuss testing and the causality of testing for COVID-19 on labor and delivery
- Describe the essential modifications necessary in medical practice for care of COVID-19 during antepartum, intrapartum, and postpartum
- Development of a communication plan with patients and families
REQUIREMENTS FOR SUCCESSFUL COMPLETION
In order to receive CME/CNE credit, you must complete these steps prior to the activity expiration date.
- View the entire presentation
- Complete the post-test with a score of 2 out of 3 or better
- Complete the online evaluation
- Submit the Completion Attestation
CREDIT
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Nebraska Medical Center, Center for Continuing Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of University of Nebraska Medical Center, Center for Continuing Education and National Emerging Special Pathogen Training and Education Center.
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is provided for 1.0 contact hour under ANCC criteria.
This enduring material has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation (ANCC) through the joint providership of the University of Nebraska Medical Center College of Nursing Continuing Nursing Education (UNMC CON CNE) (provider), University of Nebraska Medical Center, Center for Continuing Education (UNMC CCE), and National Emerging Special Pathogen Training and Education Center.
DISCLOSURE DECLARATION
As a provider accredited by ACCME, the University of Nebraska Medical Center, Center for Continuing Education, the University of Nebraska Medical Center, College of Nursing Continuing Nursing Education, and the American Nurses Credentialing Center’s Commission on Accreditation must ensure balance, objectivity, independence, and scientific rigor in its educational activities. Faculty are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or the trade names of several to ensure impartiality.
All speakers, planning committee members and others in a position to control continuing medical education content participating in a University of Nebraska Medical Center, Center for Continuing Education, University of Nebraska Medical Center, College of Nursing Continuing Nursing Education, and American Nurses Credentialing Center’s Commission on Accreditation activity are required to disclose relationships with commercial interests. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Disclosure of these commitments and/or relationships is included in these course materials so that participants in the activity may formulate their own judgments in interpreting its content and evaluating its recommendations.
This enduring material may include presentations in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications.
All materials are included with the permission of the authors. The opinions expressed are those of the authors and are not to be construed as those of the University of Nebraska Medical Center, Center for Continuing Education, University of Nebraska Medical Center, College of Nursing Continuing Nursing Education, or American Nurses Credentialing Center’s Commission on Accreditation.
The following indicates the disclosure declaration information and the nature of those commercial relationships.
FACULTY AND PLANNING COMMITTEE DISCLOSURES
The following faculty** and planning committee members have no financial relationships to disclose.
- Sarah Anderson-Fiore, MPH, CHES
- Sonia Bell, BS
- John P. Horton, MD**
- Heidi Keeler, PhD, RN
- Benjamin Mattson, MS Ed
- Jason Noble, BA, BFA
- Renee Paulin, MSN, RN, CWOCN
- Brenda Ram, CMP, CHCP
- Michelle Schwedhelm, MSN, RN, NEA-BC
- Sharon Vanairsdale, DNP, APRN, ACNS-BC, NP-C, CEN. FAEN, FAAN
- Sami Vasistha, MS
FINANCIAL SUPPORT
This program is funded by ASPR & CDC
",,,https://courses.netec.org/courses/20-web-ld,,,,"2019-nCoV,Coronavirus,COVID-19,Labor and Delivery,R-SP,R-T&C,Training",https://repository.netecweb.org/files/original/c58a77ff915bbcb55d5c8d1fb43f1520.png,"Online Course",Deploy,1,0
1204,https://repository.netecweb.org/items/show/1204,"COVID-19 Considerations for Labor & Delivery Patients","Treatment & Care","Planning, screening, testing, and medical practice considerations for pregnant, birth, labor and delivery patients.
See the related webinar on COVID-19 and Labor and Delivery patients.
Get continuing education credit through the related online course on COVID-19 and Labor and Delivery patients.",NETEC,,,2020-07-02,"2022-09-27 - general asset review - Treatment & Care group
2022-07 by Kari, Special Populations Treatment & Care group - Tag archived - no more reviews
2023-03-03 un-mark archive - in SPORSA",,"Y - D0.1Tx/D0.2Tx Qualtrics # 826",,,,,2024-03-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2019-nCoV,Archived,Coronavirus,COVID-19,Labor and Delivery,R-SP,R-T&C",https://repository.netecweb.org/files/original/83496a89e330e33749d8cbaa7483e5ed.pdf,Guide,Deploy,1,0
1043,https://repository.netecweb.org/items/show/1043,"New WHO guidelines on the management of pregnancy and breastfeeding in the context of Ebola","Treatment & Care","Providing care for pregnant and breastfeeding women with Ebola virus disease is complex and requires expertise in infectious diseases, obstetrics, and gynaecology. ","Thorson, Anna E., Megan E. Foeller, Severine Caluwaerts, Carolina Ribeiro do Valle, Ian Crozier, Gibrilla Deen, Devika Dixit, Chrissy Godwin, Pius Okong, Rachel Esteves Soeiro, João Paulo Sousa, Michel van Herp, Maurice Bucagu, Alejandro Costa, Megan Foeller, Pierre Formenty, Roopan Gill, Caron Kim, Brigitte Kini, Anais Legand, Olufemi Oladapo, Leopold Ouedraogo, Mark Perkins, Anne Thorson, and Patricia Titulaer. ",,,2020-05-06,"2022-09-27 - general asset review - Treatment & Care group (3 yr)
2022-07 by Kari, Special Populations Treatment & Care group (1 yr - went with T&C)",,"Y - D0.1Tx/D0.2Tx Qualtrics # 826",,,Publication,,2025-09-27,,,,,,,,,,"Thorson, Anna E., Megan E. Foeller, Severine Caluwaerts, Carolina Ribeiro do Valle, Ian Crozier, Gibrilla Deen, Devika Dixit, Chrissy Godwin, Pius Okong, Rachel Esteves Soeiro, João Paulo Sousa, Michel van Herp, Maurice Bucagu, Alejandro Costa, Megan Foeller, Pierre Formenty, Roopan Gill, Caron Kim, Brigitte Kini, Anais Legand, Olufemi Oladapo, Leopold Ouedraogo, Mark Perkins, Anne Thorson, and Patricia Titulaer. 2020. ""New WHO guidelines on the management of pregnancy and breastfeeding in the context of Ebola."" The Lancet Infectious Diseases.
","Free online on Lancet site.",,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30375-3/fulltext,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30375-3/fulltext,,,,"Ebola,Guidance Document,Labor and Delivery,Neonates,R-Res&Pub,R-SP,R-T&C,Viral Hemorrhagic Fever",,Publication,Discover,1,0
1042,https://repository.netecweb.org/items/show/1042,"Pregnancy and breastfeeding in the context of Ebola: a systematic review","Treatment & Care","The outbreaks of Ebola virus between 2014 and 2020 have drawn attention to knowledge gaps related to Ebola virus disease in pregnant women. The aim of this study was to systematically evaluate available data on pregnant and lactating women with acute Ebola virus disease or following recovery.","Foeller, Megan E., Carolina Carvalho Ribeiro do Valle, Timothy M. Foeller, Olufemi T. Oladapo, Elin Roos, and Anna E. Thorson.",,,2020-05-06,"2022-09-27 - general asset review - Treatment & Care group
2022-07 by Clayton, Special Populations Treatment & Care group (3 yr)",,Y,,,Publication,,2025-09-27,,,,,,,,,,"Foeller, Megan E., Carolina Carvalho Ribeiro do Valle, Timothy M. Foeller, Olufemi T. Oladapo, Elin Roos, and Anna E. Thorson. 2020. ""Pregnancy and breastfeeding in the context of Ebola: a systematic review."" The Lancet Infectious Diseases.
","Free online on Lancet site.","Summary
The outbreaks of Ebola virus between 2014 and 2020 have drawn attention to knowledge gaps related to Ebola virus disease in pregnant women. The aim of this study was to systematically evaluate available data on pregnant and lactating women with acute Ebola virus disease or following recovery. We searched MEDLINE, Embase, Cochrane Library (CENTRAL), Web of Science Core Collection, CINAHL, POPLINE, Global Health, and WHO Global Index Medicus, in addition to grey literature, for relevant articles. Studies of all types and published between database inception and Aug 19, 2019, were eligible (PROSPERO 129335). We identified 1060 records, of which 52 studies met our inclusion criteria. Overall, mortality in 274 pregnant women with Ebola virus disease was 72% (197 women died); mortality for pregnant women with Ebola virus disease were not higher than those in the general population of patients with Ebola virus disease. Nearly all women with Ebola virus disease had adverse pregnancy outcomes. Among survivors, Ebola virus RNA was detected by RT-PCR in amniotic fluid up to 32 days after maternal clearance of Ebola virus from the blood and in breastmilk 26 days after symptom onset. A risk of transmission of Ebola virus from pregnancy-related fluids and breastmilk probably exists, and precautions should be taken.
",https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30194-8/fulltext,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30194-8/fulltext,,,,"Ebola,Labor and Delivery,Neonates,R-Res&Pub,R-SP,R-T&C,Viral Hemorrhagic Fever",,Publication,Discover,1,0
978,https://repository.netecweb.org/items/show/978,"A practice of anesthesia scenario design for emergency cesarean section in patients with COVID-19 infection based on the role of standard patient","Treatment & Care","The new coronavirus (COVID-19) has been characterized as a world pandemic by WHO since March 11, 2020. Although it is likely that COVID-19 transmission is primarily via droplets and close contact, airborne transmission and fecal-oral route remains a possibility.","Kang, Yin, Longjiao Deng, Dengwen Zhang, Yuehong Wang, Gang Wang, Li Mei, Guobin Zhou, and Haihua Shu. ",,,2020-04-21,"2022-09-27 - general asset review - Treatment & Care group
2022-07 by Clayton, Special Populations Treatment & Care group
2023-12-15 by Clayton Mowrer, Special Populations Treatment & Care group - skipped, bump for next review.",,Y,,,Publication,,2024-04-27,,,,,,,,,,"Kang, Yin, Longjiao Deng, Dengwen Zhang, Yuehong Wang, Gang Wang, Li Mei, Guobin Zhou, and Haihua Shu. 2020. ""A practice of anesthesia scenario design for emergency cesarean section in patients with COVID-19 infection based on the role of standard patient."" BioScience Trends advpub.
","Advance publication pdf available online","The new coronavirus (COVID-19) has been characterized as a world pandemic by WHO since March 11, 2020. Although it is likely that COVID-19 transmission is primarily via droplets and close contact, airborne transmission and fecal-oral route remains a possibility. The medical staff working in the operating room, such as anesthesiologists, surgeons and nurses, are at high risk of exposure to virus due to closely contacting patients. The perioperative management is under great challenge while performing surgeries for patients suffering COVID-19, including emergency cesarean section, which is one of the most common surgeries under such circumstances. How to prevent medical staff from cross-infection is an issue of great concern. In this article, we give a practice of anesthesia scenario design for emergency cesarean section in a supposed standard patient suffering COVID-19, aimed to optimize the work flow and implement the protective details through simulation of a real operation scenario, which may be useful for training and clinical practice of anesthesia management for patients suffering COVID-19 or other fulminating infectious diseases.
Keywords: COVID-19, SARS-CoV-2, anesthesia management, cesarean section, scenario design",https://www.jstage.jst.go.jp/article/bst/advpub/0/advpub_2020.03066/_article/-char/en,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.jstage.jst.go.jp/article/bst/advpub/0/advpub_2020.03066/_article/-char/en,,,,"2019-nCoV,Coronavirus,COVID-19,Example,Labor and Delivery,R-Res&Pub,R-SP,R-T&C",,Publication,Discover,1,0
946,https://repository.netecweb.org/items/show/946,"NETEC COVID-19 Webinar Series (4/16/20)/Online Course: Care of Labor and Delivery Patients","Treatment & Care","Approach to care for pregnant COVID patients and those under investigation for labor and delivery, pregnancy, and childbirth.
Webinar slides attached.
See the related flyer on COVID-19 and Labor and Delivery patients.",NETEC,,,2020-04-16,"2022-09-27 - general asset review - Treatment & Care group
2023-12-15 by Clayton Mowrer, Special Populations Treatment & Care group - ""course removed""",,,,,"Webinar and Online Course",,"2024-04-27 = note says ""Course removed"" but link works? Please review",,,,,,,"
",,,,,,,,,,,,,,,," Thursday, April 16, 2020 | 3:00 PM CDT",,,,,,,,,,,,,,,,,https://youtu.be/wYo0h32bN4A,"Webinar, register at the link below.",,,"2019-nCoV,Coronavirus,COVID-19,Labor and Delivery,Not updated,R-SP,R-T&C",https://repository.netecweb.org/files/original/254a7e22bf141859ef644784c4bae0ac.pdf,Webinar,Deploy,1,0
945,https://repository.netecweb.org/items/show/945,"Universal Screening for SARS-CoV-2 in Women Admitted for Delivery","Treatment & Care","In recent weeks, Covid-19 has rapidly spread throughout New York City. The obstetrical population presents a unique challenge during this pandemic, since these patients have multiple interactions with the health care system and eventually most are admitted to the hospital for delivery.","Sutton, Desmond, Karin Fuchs, Mary D’Alton, and Dena Goffman.",,,2020-04-13,"2022-09-27 - general asset review - Treatment & Care group
2022-07 by Clayton, Special Populations Treatment & Care group
2023-12-15 by Clayton Mowrer, Special Populations Treatment & Care group - note ""new asset to replace""",,Y,,,Publication,,2024-09-27,,,,,,,,,,"Sutton, Desmond, Karin Fuchs, Mary D’Alton, and Dena Goffman. 2020. ""Universal Screening for SARS-CoV-2 in Women Admitted for Delivery."" New England Journal of Medicine.
","Free online",,https://www.nejm.org/doi/full/10.1056/NEJMc2009316,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.nejm.org/doi/full/10.1056/NEJMc2009316,,,,"2019-nCoV,Coronavirus,COVID-19,Labor and Delivery,Laboratory Testing,Not updated,R-Res&Pub,R-SP,R-T&C",,Publication,Discover,1,0
941,https://repository.netecweb.org/items/show/941,"A Spanish-translated clinical algorithm for management of suspected SARS-CoV-2 infection in pregnant women","Elementos en Español","Translation of the algorithm from the following paper to spanish:
- Favre, Guillaume, Léo Pomar, Xiaolong Qi, Karin Nielsen-Saines, Didier Musso, and David Baud. 2020. ""Guidelines for pregnant women with suspected SARS-CoV-2 infection."" The Lancet Infectious Diseases.
","Martinez-Portilla, Raigam J., Anna Goncé, Ameth Hawkins-Villarreal, and Francesc Figueras.",,,2020-04-09,,,,,,Publication,,2024-01-01,,,,,,,,,,"Martinez-Portilla, Raigam J., Anna Goncé, Ameth Hawkins-Villarreal, and Francesc Figueras. 2020. ""A Spanish-translated clinical algorithm for management of suspected SARS-CoV-2 infection in pregnant women."" The Lancet Infectious Diseases.
","Free online on Lancet site","No standardised guidelines for treating pregnant woman with SARS-CoV-2 infection are currently available in Spanish, a language with 537 million native speakers worldwide.Thus, we feel there is an urgent need to share the valuable information provided by Favre and colleagues to all countries where SARS-CoV-2 is spreading, especially Latin America. We feel this algorithm can be adequately adapted to Spanish-speaking countries where such information is urgently needed.",https://www.thelancet.com/cms/10.1016/S1473-3099(20)30285-1/attachment/9bb157ea-3ba1-42cd-8638-48cb5bfd79c5/mmc1.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30285-1/fulltext,,,,"2019-nCoV,Coronavirus,COVID-19,Español,Labor and Delivery,Neonates,R-Res&Pub,R-SP,Spanish",,Publication,,1,0
786,https://repository.netecweb.org/items/show/786,"Coronavirus Disease 2019 (COVID-19) Update—Information for Clinicians Caring for Children and Pregnant Women","Infection Control","During this COCA Call, presenters will focus on current information about COVID-19 as it relates to children and pregnant women. Topics will include infection prevention and control measures in inpatient obstetric healthcare settings (CDC’s Interim Considerations for Infection Prevention and Control of Coronavirus Disease 2019 (COVID-19) in Inpatient Obstetric Healthcare Settings) and resources available to care for pediatric patients.",CDC,,,2020-03-12,"2022-09-27 - general asset review - Clayton, Treatment & Care group - Archive - Would replace with links to current CDC/ACOG guidelines: https://www.covid19treatmentguidelines.nih.gov/special-populations/pregnancy/ - (In SPORSA No Archive)
2023-08-24 - general ongoing review IPC - Caroline and Trish
2023-12-15 by Clayton Mowrer, Special Populations Treatment & Care group - move to SP for next review (timed with IPC for now)",,Y,,,,,2026-08-24,,,,,,,,,,,,,,,,,,,,,,,"Date: Thursday, March 12, 2020
Time: 2:00 P.M. – 3:00P.M. (Eastern Time)
",,,,,,,,,,,,,,,,,https://emergency.cdc.gov/coca/calls/2020/callinfo_031220.asp,"COCA Call webinar, will be recorded.",,,"2019-nCoV,CDC,Coronavirus,COVID-19,Infection Prevention and Control,Labor and Delivery,Neonates,Patient Care,Pediatrics,R-SP",https://repository.netecweb.org/files/original/8b5c756e6403ce4443b2642583f48f1d.png,Webinar,Discover,1,0
553,https://repository.netecweb.org/items/show/553,"Pregnant Women and Vaccines Against Emerging Epidemic Threats: Ethics Guidance for Preparedness, Research, and Response ",Research,"
PREVENT Guidance
This Guidance provides a roadmap for the ethically responsible, socially just, and respectful inclusion of the interests of pregnant women in the development and deployment of vaccines against emerging pathogens. The Guidance is a product of the Pregnancy Research Ethics for Vaccines, Epidemics, and New Technologies (PREVENT) Working Group—a multidisciplinary, international team of 17 experts specializing in bioethics, maternal immunization, maternal-fetal medicine, obstetrics, pediatrics, philosophy, public health, and vaccine research and policy— in consultation with a variety of external experts and stakeholders.
The Guidance begins by setting forth an aspirational vision and makes the case for its moral importance. We then specify 22 concrete recommendations, organized around three key areas: public health preparedness, R&D, and vaccine delivery.
The recommendations are directed at a range of actors, including global and national policymakers, regional and national regulatory authorities, funders and sponsors, vaccine manufacturers, research institutions, trial networks and research groups, individual researchers, oversight bodies, ethics review committees, community advisory boards, and civil society organizations.
The Guidance is also now available in Vaccine: https://doi.org/10.1016/j.vaccine.2019.01.011
","Johns Hopkins Berman Institute of Bioethics, The Pregnancy Research Ethics for Vaccines, Epidemics, and New Technologies (PREVENT) Project","Krubiner, Carleigh B., Ruth R. Faden, Ruth A. Karron, Margaret O. Little, Anne D. Lyerly, Jon S. Abramson, Richard H. Beigi, Alejandro R. Cravioto, Anna P. Durbin, Bruce G. Gellin, Swati B. Gupta, David C. Kaslow, Sonali Kochhar, Florencia Luna, Carla Saenz, Jeanne S. Sheffield, and Paulina O. Tindana.",,2019-05-03,"2022-11-07 Clayton, Treatment & Care general asset review",,,,,Publication,,2025-11-07,,,,,,,,,,"Krubiner, Carleigh B., Ruth R. Faden, Ruth A. Karron, Margaret O. Little, Anne D. Lyerly, Jon S. Abramson, Richard H. Beigi, Alejandro R. Cravioto, Anna P. Durbin, Bruce G. Gellin, Swati B. Gupta, David C. Kaslow, Sonali Kochhar, Florencia Luna, Carla Saenz, Jeanne S. Sheffield, and Paulina O. Tindana. 2019. ""Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response."" Vaccine.","Open source - CC-BY-NC-ND","
Abstract
Zika virus, influenza, and Ebola have called attention to the ways in which infectious disease outbreaks can severely – and at times uniquely – affect the health interests of pregnant women and their offspring. These examples also highlight the critical need to proactively consider pregnant women and their offspring in vaccine research and response efforts to combat emerging and re-emerging infectious diseases. Historically, pregnant women and their offspring have been largely excluded from research agendas and investment strategies for vaccines against epidemic threats, which in turn can lead to exclusion from future vaccine campaigns amidst outbreaks. This state of affairs is profoundly unjust to pregnant women and their offspring, and deeply problematic from the standpoint of public health. To ensure that the needs of pregnant women and their offspring are fairly addressed, new approaches to public health preparedness, vaccine research and development, and vaccine delivery are required. This Guidance offers 22 concrete recommendations that provide a roadmap for the ethically responsible, socially just, and respectful inclusion of the interests of pregnant women in the development and deployment of vaccines against emerging pathogens. The Guidance was developed by the Pregnancy Research Ethics for Vaccines, Epidemics, and New Technologies (PREVENT) Working Group – a multidisciplinary, international team of 17 experts specializing in bioethics, maternal immunization, maternal-fetal medicine, obstetrics, pediatrics, philosophy, public health, and vaccine research and policy – in consultation with a variety of external experts and stakeholders.
Keywords
Epidemics
Pregnancy
Emerging infectious diseases
Maternal immunization
Public health ethics
Research ethics
Vaccines
Research & development
",https://www.sciencedirect.com/science/article/pii/S0264410X19300453?via%3Dihub,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.sciencedirect.com/science/article/pii/S0264410X19300453?via%3Dihub,,,,"Epidemic,Ethics,Labor and Delivery,Neonates,Pediatrics,Public Health,R-Res&Pub,R-SP,Research,Treatment and Care,Vaccine Study",https://repository.netecweb.org/files/original/f49f01cc54c5c9d2e5a0de305a902d74.pdf,Publication,Deploy,1,0
549,https://repository.netecweb.org/items/show/549,"Ebola Infection in Pregnancy","Treatment & Care","The 2014-2016 Ebola outbreak primarily based in 3 West African countries, had far-reaching global effects.","Haddad, Lisa B., John Horton, Bruce S. Ribner, and Denise J. Jamieson.",,,2018-03,"2022-09-27 - general asset review - Treatment & Care group (3 yr)
2022-07 - general asset review - Clayton, SP Treatment & Care group (1 yr - went with T&C)",,,,,Publication,,2025-09-27,,,,,,,,,,"Haddad, Lisa B., John Horton, Bruce S. Ribner, and Denise J. Jamieson. 2018. ""Ebola Infection in Pregnancy: A Global Perspective and Lessons Learned."" Clinical obstetrics and gynecology 61 (1):186-96.
","Author manuscript free on PubMedCentral.","Abstract
The 2014-2016 Ebola outbreak primarily based in 3 West African countries, had far-reaching global effects. Importantly, the crisis highlighted large gaps in reproductive health services in affected countries and inadequate healthcare system preparedness for obstetrical patients in the setting of highly contagious infectious diseases. We aim to review Ebola virus effects with a focus on the obstetrical implications in the context of this recent Ebola outbreak, discuss the lessons learned following this outbreak and propose current measures specific to obstetrics that should be considered in preparation for the next concerning emergent infectious disease.
Keywords: Ebola, obstetrics, pregnancy, haemorrhagic fever
",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776722/,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/29351152,,,,"Ebola,Labor and Delivery,R-Res&Pub,R-SP,R-T&C,Viral Hemorrhagic Fever",https://repository.netecweb.org/files/original/9fe1e3e6156e2273a7c41dd8ff857740.png,Publication,Discover,1,0
548,https://repository.netecweb.org/items/show/548,"Pregnant Women and the Ebola Crisis","Treatment & Care","On August 1, 2018, the Ministry of Health of the Democratic Republic of Congo (DRC) reported the emergence of another Ebola virus outbreak, the 10th in the DRC since the virus was discovered in 1976. As of November 13, 2018, there were 341 cases and 215 deaths, making this the world’s third-largest Ebola outbreak to date. The public health community learned several lessons when West Africa experienced the largest-ever Ebola outbreak beginning in 2014, which ultimately included 28,000 cases and caused 11,000 deaths. Current prevention and control measures have benefited from these lessons and are directed toward a coordinated response, including improvements in cross-border surveillance, laboratory capacity, case management, infection control at health facilities, culturally sensitive safe burials, and psychosocial care, as well as inclusion of vaccination as a control measure. However, according to available documents, issues related to pregnant women have been largely ignored in these efforts.","Haddad, Lisa B., Denise J. Jamieson, and Sonja A. Rasmussen. ",,,2018-12-27,"2022-09-27 - general asset review - Treatment & Care group (3 yr)
2022-07 - general asset review - Clayton, SP Treatment & Care group",,,,,Publication,,2025-09-27,,,,,,,,,,"Haddad, Lisa B., Denise J. Jamieson, and Sonja A. Rasmussen. 2018. ""Pregnant Women and the Ebola Crisis."" New England Journal of Medicine 379 (26):2492-3.","Read online on Journal website",,https://www.nejm.org/doi/full/10.1056/NEJMp1814020,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/30485156,,,,"Contact Transmission,Ebola,Epidemiology,Infection Prevention and Control,Labor and Delivery,Neonates,Outbreaks,R-Res&Pub,R-SP,R-T&C,Vaccine Study",https://repository.netecweb.org/files/original/78cee186cf2c178d2f7c095465050d06.png,Publication,Discover,1,0
539,https://repository.netecweb.org/items/show/539,"Pregnancy, Labor, and Delivery after Ebola Virus Disease and Implications for Infection Control in Obstetric Services, United States","Infection Control","Many of the survivors of the 2014–2015 epidemic of Ebola virus disease (EVD) in West Africa were women of childbearing age. ","Kamali, Amanda, Denise J. Jamieson, Julius Kpaduwa, Sarah Schrier, Moon Kim, Nicole M. Green, Ute Ströher, Atis Muehlenbachs, Michael Bell, Pierre E. Rollin, and Laurene Mascola.",,CDC,2016-07,"2022-11-07 - Clayton, Treatment & Care group general asset review (1 year)
2022-01-10 by PPE group Shawn Gibbs (3 years)",,,,,Publication,,2023-11-07,,,,,,,,,,"Kamali, Amanda, Denise J. Jamieson, Julius Kpaduwa, Sarah Schrier, Moon Kim, Nicole M. Green, Ute Ströher, Atis Muehlenbachs, Michael Bell, Pierre E. Rollin, and Laurene Mascola. 2016. ""Pregnancy, Labor, and Delivery after Ebola Virus Disease and Implications for Infection Control in Obstetric Services, United States."" Emerging infectious diseases 22 (7):1156-61.
","Free Online","Many of the survivors of the 2014–2015 epidemic of Ebola virus disease (EVD) in West Africa were women of childbearing age. Limited clinical and laboratory data exist that describe these women’s pregnancies and outcomes. We report the case of an EVD survivor who became pregnant and delivered her child in the United States, and we discuss implications of this case for infection control practices in obstetric services. Hospitals in the United States must be prepared to care for EVD survivors.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918171/,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918171/,,,,"Ebola,Infection Prevention and Control,Labor and Delivery,Neonates,Personal Protective Equipment (PPE),R-SP,Survivors",https://repository.netecweb.org/files/original/8043910a352df6663083faf95c0b434a.pdf,Publication,Discover,1,0
537,https://repository.netecweb.org/items/show/537,"Ebola virus disease and pregnancy - A review of the current knowledge of Ebola virus pathogenesis, maternal and neonatal outcomes",Research,"The 2014-2016 Ebola virus disease (EVD) outbreak in West Africa devastated local health systems and caused thousands of deaths.","Bebell, Lisa M., Titilope Oduyebo, and Laura E. Riley.",,,2017-03-15,"2022-07 by Kari, Special Populations Treatment & Care group",,,,,Publication,,2024-07-31,,,,,,,,,,"Bebell, Lisa M., Titilope Oduyebo, and Laura E. Riley. 2017. ""Ebola virus disease and pregnancy: A review of the current knowledge of Ebola virus pathogenesis, maternal, and neonatal outcomes."" Birth Defects Res 109 (5):353-62.
","Author manuscript free on PubMed; final article through Wiley","The 2014-2016 Ebola virus disease (EVD) outbreak in West Africa devastated local health systems and caused thousands of deaths. Historical reports from Zaire ebolavirus outbreaks suggested pregnancy was associated with an increased risk of severe illness and death, with mortality rates from 74-100%. In total, 111 cases of pregnant patients with EVD are reported in the literature, with an aggregate maternal mortality of 86%. Pregnancy-specific data published from the recent outbreak include four small descriptive cohort studies and five case reports. Despite limitations including reporting bias and small sample size, these studies suggest mortality in pregnant women may be lower than previously reported, with five of 13(39%) infected women dying. Optimal treatments for pregnant women, and differences in EVD course between pregnant women and non-pregnant individuals are major scientific gaps that have not yet been systematically addressed. Ebola virus may be transmitted from mother to baby in utero, during delivery, or through contact with maternal body fluids after birth including breast milk. EVD is almost universally fatal to the developing fetus, and limited fetal autopsy data prevent inferences on risk of birth defects. Decisions about delivery mode and other obstetric interventions should be individualized. WHO recommends close monitoring of survivors who later become pregnant, but does not recommend enhanced precautions at subsequent delivery. Though sexual transmission of Ebola virus has been documented, birth outcomes among survivors have not been published and will be important to appropriately counsel women on pregnancy outcomes and inform delivery precautions for healthcare providers.",https://www.ncbi.nlm.nih.gov/pubmed/28398679,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407292/,,,,"Labor and Delivery,Outcomes,R-Res&Pub,R-SP,Vaccine Study",https://repository.netecweb.org/files/original/d995fc21bf0d3b30f3646e6aabeaef30.png,Publication,Discover,1,0
536,https://repository.netecweb.org/items/show/536,"Guidance for Screening and Caring for Pregnant Women with Ebola Virus Disease for Healthcare Providers in U.S. Hospitals","Treatment & Care","Key Points
- Healthcare providers caring for pregnant women in U.S. hospitals should be prepared to screen patients for EVD and have a plan in place to triage these patients.
- Obstetric management of pregnant women with EVD, particularly decisions about mode of delivery for women in labor, needs to consider risks to the woman, risks of exposure for healthcare providers, and potential benefits to the neonate.
- Healthcare workers who are pregnant should not care for patients with EVD.
- Pregnant PUIs or patients with confirmed EVD should be hospitalized, and CDC guidance for hospitalized PUIs or patients with confirmed EVD should be followed.
",CDC,,,2018-05-30,"2022-09-27 - general asset review - Treatment & Care group",,Y,,,,,2025-09-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"
Who this is for: Healthcare providers working in emergency departments and labor and delivery units in U.S. hospitals.
What this is for: Guidance on how to screen pregnant women for Ebola virus disease (EVD) and how to care for pregnant women as patients under investigation (PUIs) for or with confirmed EVD, including considerations for pregnant healthcare workers.
How to use: This guidance is intended to help U.S. hospitals develop a plan for screening and treating pregnant PUIs or patients with confirmed EVD.
",,,https://www.cdc.gov/vhf/ebola/clinicians/evd/pregnant-women.html,,,,"Ebola,Labor and Delivery,R-SP,R-T&C",https://repository.netecweb.org/files/original/84ca03c4be00e1f9e6cdfcf23a699a76.png,Guide,Develop,1,0
433,https://repository.netecweb.org/items/show/433,"Labor and Delivery Ebola Readiness and Protocols","Treatment & Care","NETEC past class slides 2015-2016",NETEC,"John P Horton, M.D.",,2016,"2022-09-27 - general asset review - Treatment & Care group",,,,,,,2025-09-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Ebola,Example,Labor and Delivery,R-T&C",https://repository.netecweb.org/files/original/6c9457a1f92b2c9a7f252ca721def11c.pdf,"In Person Course",Discover,1,0